OrthoPediatrics closed its initial public offering of 4.6MM shares of common stock at $13/share, including the full exercise of an option for underwriters to purchase 600,000 additional shares. Gross proceeds equalled US $59.8MM. Shares are now trading on NASDAQ as KIDS.
Funds will pay accumulated and unpaid dividends on Series B preferred stock, cover implants and instrument sets for consignment, fund R&D, grow sales and marketing programs and support working capital/general corporate purposes.
OrthoPediatrics closed its initial public offering of 4.6MM shares of common stock at $13/share, including the full exercise of an option for underwriters to purchase 600,000 additional shares. Gross proceeds equalled US $59.8MM. Shares are now trading on NASDAQ as KIDS.
Funds will pay accumulated and unpaid dividends on Series B preferred...
OrthoPediatrics closed its initial public offering of 4.6MM shares of common stock at $13/share, including the full exercise of an option for underwriters to purchase 600,000 additional shares. Gross proceeds equalled US $59.8MM. Shares are now trading on NASDAQ as KIDS.
Funds will pay accumulated and unpaid dividends on Series B preferred stock, cover implants and instrument sets for consignment, fund R&D, grow sales and marketing programs and support working capital/general corporate purposes.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
